NCT01781429 2020-03-20Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced MalignanciesBioMed Valley Discoveries, IncPhase 1/2 Completed136 enrolled 25 charts